| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.14B | -6.1% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 27.9% | Net margin -6.6% |
| Revenue Q/Q | -25.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.10B | 72.1% |
| R&D | ¥0.01B | 8.5% |
| SG&A | ¥0.04B | 26.3% |
| Tax & other | ¥-0.00B | -0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
康泰医学 ・ 欧陆通 ・ 回盛生物 ・ 天阳科技 ・ 海晨股份 ・ 捷强装备 ・ 蒙泰高新 ・ 金春股份 ・ 维康药业 ・ 大叶股份 ・ 迦南智能 ・ 盛德鑫泰
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies